Identification of PSE and OXA β-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism

被引:125
作者
Bert, F [1 ]
Branger, C [1 ]
Lambert-Zechovsky, N [1 ]
机构
[1] Hop Beaujon, Dept Microbiol, F-92110 Clichy, France
关键词
D O I
10.1093/jac/dkf069
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: A method using PCR-restriction fragment length polymorphism was developed to identify Pseudomonas aeruginosa beta-lactamase genes. Methods: Two hundred and fifty-nine P. aeruginosa isolates were screened by PCR with 11 primer pairs designed to detect genes encoding PSE, OXA, TEM and SHV enzymes. PSE and OXA gene variants were distinguished by restriction of PCR products with endonucleases recognizing sites involved in point mutations. Nucleotide sequences were verified for a few isolates by sequencing the PCR products. Results: Four isolates produced extended-spectrum beta-lactamases (ESBLs) according to the double disc synergy test. PCR detecting bla(PSE) genes was positive in 162 (62.5%) isolates: 151 carried bla(PSE-1) and 11 carried a variant encoding an enzyme differing from PSE-1 by a single amino acid substitution (Pro102 to Ser). PCR detecting sequences for enzymes of the OXA-10 group was positive in 68 (26.3%) isolates: 31 carried bla(OXA-10), one carried bla(OXA-14) and 36 carried a new variant intermediate between bla(OXA-13) and bla(OXA-19). The bla(OXA-2) gene was identified in 13 (5%) isolates. Two other isolates carried bla(OXA-2) variants encoding ESBLs differing from OXA-2 by a single amino acid substitution (Asp150 to Tyr and Trp159 to Cys, respectively). PCR detecting sequences for enzymes of the OXA-1 group was positive in 12 (4.6%) isolates. A bla(TEM) gene was identified in five (1.9%) isolates (three bla(TEM-1), one bla(TEM-2), one bla(TEM-4)). Conclusion: This approach is effective for screening P. aeruginosa for beta-lactamase gene carriage in epidemiological studies and for detecting new variants.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 31 条
  • [1] ARLET G, 1995, FEMS MICROBIOL LETT, V134, P203, DOI 10.1111/j.1574-6968.1995.tb07938.x
  • [2] Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa
    Aubert, D
    Poirel, L
    Chevalier, J
    Leotard, S
    Pages, JM
    Nordmann, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) : 1615 - 1620
  • [3] BOISSINOT M, 1990, J BIOL CHEM, V265, P1225
  • [4] Antibiotic susceptibility and mechanisms of β-lactam resistance in 1310 strains of Pseudomonas aeruginosa:: a French multicentre study (1996)
    Cavallo, JD
    Fabre, R
    Leblanc, F
    Nicolas-Chanoine, MH
    Thabaut, A
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (01) : 133 - 136
  • [5] MECHANISMS OF RESISTANCE TO BETA-LACTAM ANTIBIOTICS AMONGST PSEUDOMONAS-AERUGINOSA ISOLATES COLLECTED IN THE UK IN 1993
    CHEN, HY
    YUAN, M
    LIVERMORE, DM
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1995, 43 (04) : 300 - 309
  • [6] PHYLOGENY OF LCR-1 AND OXA-5 WITH CLASS-A AND CLASS-D BETA-LACTAMASES
    COUTURE, F
    LACHAPELLE, J
    LEVESQUE, RC
    [J]. MOLECULAR MICROBIOLOGY, 1992, 6 (12) : 1693 - 1705
  • [7] SEQUENCE OF THE OXA2 BETA-LACTAMASE - COMPARISON WITH OTHER PENICILLIN-REACTIVE ENZYMES
    DALE, JW
    GODWIN, D
    MOSSAKOWSKA, D
    STEPHENSON, P
    WALL, S
    [J]. FEBS LETTERS, 1985, 191 (01) : 39 - 44
  • [8] OXA-16, a further extended-spectrum variant of OXA-10 β-lactamase, from two Pseudomonas aeruginosa isolates
    Danel, F
    Hall, LMC
    Gur, D
    Livermore, DM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (12) : 3117 - 3122
  • [9] OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strain
    Danel, F
    Hall, LMC
    Gur, D
    Livermore, DM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (04) : 785 - 790
  • [10] OXA-17, a further extended-spectrum variant of OXA-10 β-lactamase, isolated from Pseudomonas aeruginosa
    Danel, F
    Hall, LMC
    Duke, B
    Gur, D
    Livermore, DM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) : 1362 - 1366